You are here :
Home
Healthcare
Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market
Global Drug Delivery Formulations Market Research Report
- Report Code: DR 1000
- Publish Date: Upcoming
Drug Delivery Formulations and its peer markets - Pharmaceutical Manufacturing Equipment, Contract Manufacturing Organizations, Next Generation Sequencing (NGS), Chromatography, Digital Pathology, Immunoassay, Contract Research Organization (CRO), Pharmaceutical Packaging Equipment, E-Clinical Trial Solutions and 8 other markets - adds up to total Pharmaceuticals market.
Drug Delivery Formulations can be segmented by Submarkets and Technologies. Submarkets of this market are Drug Delivery Technology. Technologies of this market are Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Nasal Drug Delivery and Ocular Drug Delivery.
Drug Delivery Formulations can be segmented by Submarkets and Technologies. Submarkets of this market are Drug Delivery Technology. Technologies of this market are Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Nasal Drug Delivery and Ocular Drug Delivery.
Key Questions Answered
- What are market estimates and forecasts; which of Drug Delivery Formulations markets are doing well and which are not?
- This reports provides most granular segmentation on Drug Delivery Technology.
- This report provides market sizing and forecast for the Drug Delivery Formulations market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
- Global Drug Delivery Formulations companies
- Manufacturing Companies
- Traders, distributors, and suppliers
- Governmental and research organizations
- Associations and industry bodies
- Technology providers
What makes our report unique?
Audience for this report
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Drug Delivery Technology
5 By Technologies
5.1 Oral Drug Delivery
5.2 Transmucosal Drug Delivery
5.3 Topical Drug Delivery
5.4 Nasal Drug Delivery
5.5 Ocular Drug Delivery
Please fill in the form below to receive a free copy of the Summary of this Report
Custom Market Research Services
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Global Oral Drug Delivery Market The Global Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $64.3 billion in 2013 and expected to be $100.8 billion by 2018, growing at a CAGR of 9.4%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd. |
Upcoming |
|
|
Global Transmucosal Drug Delivery Market The Global Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.91 billion in 2013 and expected to be $4.05 billion by 2018, growing at a CAGR of 6.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs. |
Upcoming |
|
|
Global Topical Drug Delivery Market The Global Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $9.44 billion in 2013 and expected to be $11.21 billion by 2018, growing at a CAGR of 3.5%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc. |
Upcoming |
|
|
Global Nasal Drug Delivery Devices Market The Global Nasal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $9.94 billion in 2013 and expected to be $15.02 billion by 2018, growing at a CAGR of 8.6%. The Nasal Drug Delivery Devices Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
Ocular Drug Delivery Ocular Drug Delivery and Oral Drug Delivery, |
Upcoming |
|
|
Controlled Release Controlled Release and Orodispersible Tablets (ODT) And Taste Masking adds up to total |
Upcoming |
|
|
Orodispersible Tablets (ODT) And Taste Masking Orodispersible Tablets (ODT) And Taste Masking and Controlled Release adds up to total |
Upcoming |
|
|
Eye Drops Eye Drops and Ointments And Gels adds up to total Ocular... |
Upcoming |
|
|
Ointments And Gels Ointments And Gels and Eye Drops adds up to total Ocular Drug... |
Upcoming |
|
|
Nasal Drops Submarkets of this market are Drug Delivery Technology. Key Questions Answered What are market estimates and forecasts; which of Nasal Drops markets are doing well and which are not? What makes... |
Upcoming |
|
|
Semi-Solid Formulations Semi-Solid Formulations and Liquid Formulations and Solid... |
Upcoming |
|
|
Liquid Formulations Liquid Formulations and Semi-Solid Formulations and |
Upcoming |
|
|
Solid Formulations Solid Formulations and Semi-Solid Formulations and |
Upcoming |
|
|
Oral (Buccal And Sublingual) Submarkets of this market are Drug Delivery Technology. Key Questions Answered What are market estimates and forecasts; which of Oral (Buccal And Sublingual) markets are doing well and which are not? ... |
Upcoming |
|
|
North American Oral Drug Delivery Market The North American Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $29.0 billion in 2013 and expected to be $43.7 billion by 2018, growing at a CAGR of 8.6%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd. |
Upcoming |
|
|
European Oral Drug Delivery Market The European Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $16.9 billion in 2013 and expected to be $24.6 billion by 2018, growing at a CAGR of 7.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd. |
Upcoming |
|
|
Asian Oral Drug Delivery Market The Asian Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $10.9 billion in 2013 and expected to be $19.8 billion by 2018, growing at a CAGR of 12.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd. |
Upcoming |
|
|
North American Nasal Drug Delivery Market The North American Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.49 billion in 2013 and expected to be $6.62 billion by 2018, growing at a CAGR of 8.1%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
European Nasal Drug Delivery Market The European Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.95 billion in 2013 and expected to be $4.14 billion by 2018, growing at a CAGR of 7.0%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
Asian Nasal Drug Delivery Market The Asian Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.51 billion in 2013 and expected to be $2.69 billion by 2018, growing at a CAGR of 12.2%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
Drug Delivery Formulations
